VSee Health, Inc. Business Combination, Acquisition Related Costs
VSee Health, Inc. (VSEE) reported Business Combination, Acquisition Related Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-03-31
- VSee Health, Inc. business combination, acquisition related costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. business combination, acquisition related costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. business combination, acquisition related costs for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. business combination, acquisition related costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. business combination, acquisition related costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- VSee Health, Inc. business combination, acquisition related costs for fiscal 2024 was $792.80K, a 813.37% increase from fiscal 2023.
- VSee Health, Inc. business combination, acquisition related costs for fiscal 2023 was $86.80K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 3 month as first filed | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 6 month as first filed | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 9 month as first filed | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-20 | $0.00 10-Q · filed 2025-11-14 | $82.32K derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2025-06-30 | $0.00 10-Q/A · filed 2025-11-20 | $0.00 10-Q/A · filed 2025-11-20 | $82.32K derived: sum of 3 quarters · filed 2026-03-31 | $538.15K derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-10-15 | $82.32K derived: sum of 2 quarters · filed 2026-03-31 | $538.15K derived: sum of 3 quarters · filed 2026-03-31 | $766.46K derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2024-12-31 | $82.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $538.15K derived: sum of 2 quarters · filed 2026-03-31 | $766.46K derived: sum of 3 quarters · filed 2026-03-31 | $792.80K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $455.83K 10-Q · filed 2025-11-14 | $646.30K 10-Q · filed 2024-11-14 | $684.14K derived: sum of 2 quarters · filed 2025-11-20 | $710.48K 10-Q · filed 2025-11-14 | $1.65M 10-Q · filed 2024-11-14 | $730.87K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-06-30 | $228.31K 10-Q/A · filed 2025-11-20 | $980.81K 10-Q · filed 2024-09-23 | $254.65K 10-Q/A · filed 2025-11-20 | $1.01M 10-Q · filed 2024-09-23 | $275.03K derived: sum of 3 quarters · filed 2025-11-20 | $284.10K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-03-31 | $26.34K 10-Q · filed 2025-10-15 | $46.73K derived: sum of 2 quarters · filed 2025-10-15 | $55.79K derived: sum of 3 quarters · filed 2025-10-15 | $71.85K derived: sum of 4 quarters · filed 2025-10-15 | |||
| 2023-12-31 | $20.39K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $29.45K derived: sum of 2 quarters · filed 2025-08-29 | $45.51K derived: sum of 3 quarters · filed 2025-08-29 | $86.80K 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | $9.07K 10-Q · filed 2024-11-14 | $25.13K derived: sum of 2 quarters · filed 2024-11-14 | $66.41K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $16.06K 10-Q · filed 2024-09-23 | $57.34K 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |